Induction of CYP1A1 and CYP2E1 in rat liver by histamine: Binding and kinetic studies

Archives of Toxicology

Volumn 81, Issue 10, 2007, Pages 697-709

  Dávila Borja, Víctor M ^a   Belmont, Javier A ^a   Espinosa, J Javier ^a   Moreno Sánchez, Rafael ^b   Albores, Arnulfo ^c   Montero, Regina D ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^c DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Catalytic inhibition; CYP1A1; CYP2E1; Histamine; Induction

Indexed keywords

AROMATIC HYDROCARBON; CYTOCHROME P450 1A1; CYTOCHROME P450 2E1; ETHOXYRESORUFIN; HISTAMINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING KINETICS; CARCINOGENESIS; CLINICAL STUDY; CONTROLLED STUDY; DEALKYLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; LIPID OXIDATION; LIVER INJURY; LIVER MICROSOME; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALS; CARCINOGENS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP2E1; DEALKYLATION; ENZYME INDUCTION; HISTAMINE; LIVER; MALE; MICROSOMES, LIVER; NADP; OXAZINES; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN BINDING; PROTEIN ISOFORMS; RATS; RATS, WISTAR;

RATTUS;

EID: 34848861870     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00204-007-0202-9     Document Type: Article

References (58)

1. Aitken AE, Richardson TA, Morgan ET (2006) Regulation of drug-metabolozing enzymes and transporters in inflammation. Annu Rev Pharmacol Toxicol 46:123-149. doi:10.1146/annurev.pharmtox.46.120604.141059
2. Anichtchik OV, Rinne JO, Kalimo H, Panula P (2000) An altered histaminergic innervation of the substantia nigra in Parkinson's disease. Exp Neurol 163:20-30. doi:10.1006/exnr.2000.7362
3. Badary O, AbdEl-Gawad H, Taha R, Ali A, Hamada F (2003) Effects of benzo[a]pyrene on tissue activities of metabolizing enzymes and antioxidant system in normal and protein-malnourished rats. J Biochem Mol Toxicol 17:86-91. doi:10.1002/jbt.10064
4. Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principal of protein- dye binding. Anal Biochem 72:248-254
5. Brandes LJ, Sukhu B, Bogdanovic P (1990) Does intracellular histamine mediate mast cell histamine release, as an intracellular messenger. Biochem Biophys Res Commun 167:665-672. doi:10.1016/0006-291X(90)92077-D
6. Brandes LJ, Bogdanovic P, Tong J, Davie JR, LaBella FS (1992) Intracellular histamine and liver regeneration: high affinity binding of histamine to chromatin, low affinity binding to matrix, and depletion of nuclear storage pool following partial hepatectomy. Biochem Biophys Res Commun 184:840-847. doi:10.1016/0006-291X(92)90666-9
7. Brandes LJ, Queen GM, LaBella FS (1997) Salutary clinical response of prostate cancer to antiandrogen withdrawal: assessment of flutamide in an in vitro parameter predictive of tumor growth enhancement. Clin Cancer Res 3:1357-1361
8. Brandes LJ, Queen GM, LaBella FS (1998) Potent interaction of histamine and polyamines at microsomal cytochorme P450, nuclei and chromatin from rat hepatocytes. J Cell Biochem 69:233-243. doi:10.1002/(SICI)1097-4644(19980601)69: 3<233::AID-JCB1>3.0.CO;2-S
9. Brandes LJ, Queen GM, LaBella FS (2000) N,N-diethyl-2[4(phenylmethyl) phenoxy] ethanamine (DPPE), a chemopotentiating and cytoprotective agent in clinical trials: interaction with histamine of cytochrome P450 3A4 and other isozymes that metabolize antineoplastic drugs. Cancer Chemother Pharmacol 45:298-304. doi:10.1007/s002800050044
10. Burke M, Thompson S, Weavwer R, Wolf C, Mayer R (1994) Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. Biochem Pharmacol 48:923-936
11. Caro A, Cederbaum A (2004) Oxidative stress, toxicology, and pharmacology of CYP2E1. Annu Rev Pharmacol Toxicol 44:27-42. doi:10.1146/annurev.pharmtox. 44.101802.121704
12. Delescluse C, Lemaire G, De Sousa G, Ramani R (2000) Is CYP1A1 induction always related to AHR signaling pathway? Toxicology 153:73-82. doi:10.1016/S0300-483X(00)00305-X
13. Dy M, Schneider E (2004) Histamine-cytokine connection in immunity and haematopoiesis. Cytokine Growth Factor Rev 15:393-410. doi:10.1016/j.cytogfr. 2004.06.003
14. Eliasson E, Johansson I, Ingelman-Sundberg M (1988) Ligand-dependent maintenance ethanol-inducible cytochrome P-450 in primary rat hepatocyte cell cultures. Biochem Biophys Res Commun 150:436-443. doi:10.1016/0006-291X(88) 90539-6
15. Escobar-Garcia D, Camacho-Carranza R, Perez I, Dorado V, Arriaga-Alba M, Espinosa-Aguirre J (2001) S9 induction by the combined treatment with cyclohexanol and albendazole. Mutagenesis 16:523-528
16. Falus A, Hegyesi H, Lazar-Molnar E, Pos Z, Laszlo V, Darvas Z (2001) Paracrine and autocrine interactions in melanoma: histamine is a relevant player in local regulation. Trends Immunol 22:648-652. doi:10.1016/S1471-4906(01) 02050-6
17. Fogel WA, Chmielecki C, Gralek M, Maslinski C (1990) Histamine metabolism in diabetic rats. Agents Actions 30:243-246
18. Graham J, Higgins J (1993) Biomembrane protocols: isolation and analysis. Methods Mol Biol 19:1-18
19. Guengerich FP, Wang P, Davidson NK (1982) Estimation of isozymes of microsomal cytochorme P450 in rats, rabbits and humans using immunochemical staining coupled with sodium dodecyl sulphate-polyacrylamide gel electrophoresis. Biochemistry 21:1698-1706
20. Heath-Pagliuso S, Rogers W, Tullis K, Seidel S, Cenijn P, Brouwer A, Denison M (1998) Activation of the Ah receptor by tryptophan and tryptophan metabolites. Biochemistry 37:11508-11515. doi:10.1021/bi980087p
21. Hellstrand K, Hermodsson S, Naredi P, Mellqvist U, Brune M (1998) Histamine and cytokine therapy. Acta Oncol 37:347-353. doi:10.1080/ 028418698430566
22. Horecker B, Kornberg A (1948) The extinction coefficients of the reduced band of pyridine nucleotides. J Biol Chem 175:385-390
23. Hornyak S, Gehlsen K, Haaparanta T (2003) Histamine dihydrochloride protects againts early alcohol-induced liver injury in a rat model. Inflammation 27:317-327. doi:10.1023/A:1026032611643
24. ICGEB (International Centre for Genetic Engineering and Biotechnology) (2007). http://www.icgeb.trieste.it/
25. Jefcoate CR (1978) Measurement of substrate and inhibitor binding to microsomal cytochrome P-450 by optical difference spectroscopy. Methods Enzymol 52:258-279
26. Jezek P, Hlavata L (2005) Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. Int J Biochem Cell Biol 37:2478-2503. doi:10.1016/j.biocel.2005.05.013
27. Jigorel E, Vee M, Boursier-Neyret C, Bertrand M, Fardel O (2005) Functional expression of sinusoidal drug transporters in primary human and rat hepatocytes. Drug Metab Dispos 33:1418-1422. doi:10.1124/dmd.105.004762
28. Kahlson G, Rosengren E (1968) New approaches to the physiology of histamine. Physiol Rev 48:155-196
29. Karavodin L, Jensen R, Sarno M, Gehlsen K (2003) Toxicology and toxicokinetics of acute and subchronic administration of histamine dihydrochloride in rats. Drug Chem Toxicol 26:35-49
30. Kumaki K, Sato M, Kon H, Nebert DW (1978) Correlation of type I, type II, and reverse type I difference spectra with absolute changes in spin state of hepatic microsomal cytochrome P-450 iron from five mammalian species. J Biol Chem 253:1048-1058
31. LaBella FS, Queen GM, Brandes LJ (2000) Interactive binding at cytochrome P450 of cell growth regulatory bioamines, steroid hormones, antihormones and drugs. J Cell Biochem 76:686-694
32. Lintunen M, Hyytiä P, Sallmen T, Karlstedt K, Tuomisto L, Leurs R, Kiianmaa K, Korpi ER, Panula P (2001) Increased brain histamine in an alcohol-preferring rat line, and modulation of ethanol consumption by H3 receptor mechanisms. FASEB J 15:1074-1076. doi:10.1096/fj.00-0545fje
33. Ma Q (2001) Induction of CYP1A1. The AhR/DRE paradigm: transcription, receptor regulation, and expanding biological roles. Curr Drug Metab 2:149-164
34. Maron D, Ames B (1983) Revised methods for Salmonella mutagenicity test. Mutat Res 113:173-215
35. Mates M, Sanchez-Jimenez F (2000) Role of reactive oxygen species in apoptosis: implications for cancer therapy. Int J Biochem Cell Biol 32:157-170
36. 1. Mutagenesis 18:211-216
37. Morris CQ, Tucker GT, Crewe HK, Harlow JR, Woods HF, Lennard MS (1989) Histamine inhibition of mixed function oxidase activity in rat and human liver microsomes and in the isolated perfused rat liver. Biochem Pharmacol 38:2639-2644
38. Navas J, Chana A, Herradon B, Segner H (2003) Induction of CYP1A by the N-imidazole derivative, 1-benzylimidazole. Environ Toxicol Chem 22:830-836
39. Nebert DW (1991) Proposed role of drug-metabolizing enzymes: regulation of steady state levels of the ligands that effect growth, homeostasis, differentiation, and neuroendocrine functions. Mol Endocrinol 5:1203-1214
40. Ogasawara M, Yamauchi K, Satoh Y, Yamaji R, Inui K, Jonker J, Schinkel A, Maeyama K (2006) Recent advances in molecular pharmacology of the histamine systems: organic cation transporters as a histamine transporter and histamine metabolism. J Pharmacol Sci 101:24-30. doi:10.1254/jphs.FMJ06001X6
41. Omura T, Sato R (1964) The carbon monoxide-binding pigment of liver microsomes. J Biol Chem 239:2370-2378
42. Ortiz de Montellano PR (2005) Cytochorme P450: structure, mechanism and biochemistry, 3rd edn. Kluwer/Plenum, New York
43. Phillips I, Shepard E (1998) Cytochrome P450 protocols. Methods Mol Biol 107:25-33
44. Reinke L, Moyer M (1985) p-nitrophenol hydroxylation: a microsomal oxidation which is highly inducible by ethanol. Drug Metab Dispos 13:548-552
45. Rogerson TD, Wilkinson CF, Hetarski K (1976) Steric factors in the inhibitory interaction of imidazoles with microsomal enzymes. Biochem Pharmacol 26:1039-1042. doi:10.1016/0006-2952(77)90241-6
46. Rönnberg AL, Hansson C, Drakenberg T, Hakanson R (1984a) Reaction of histamine with o-phthalaldehyde: isolation and analysis of the fluorophore. Anal Biochem 139:329-337
47. Rönnberg AL, Hansson C, Hakanson R (1984b) High-performance liquid chromatographic determination of histamine in biological samples after derivation with o-phtalaldehyde. Anal Biochem 139:338-344
48. Santini R, Myrand S, Elferink C, Reiners J (2001) Regulation of CYP1A1 induction by dioxin as a function of cell cycle phase. J Pharmacol Exp Ther 299:718-728
49. Schenkman JB (1970) Studies on the structure of the type I and type II spectral changes in liver microsomes. Biochemistry 9:2081-2091
50. Segel IH (1975) Enzyme kinetics: behavior and analysis of rapid equilibrium and steady-state enzyme systems. Wiley, New York
51. Senler TI, Dean WL, Pierce WM, Wittliff JL (1985) Procedures for measuring cytochrome P-450 dependent hydroxylation activity in reproductive tissues. Anal Biochem 144:152-158. doi:10.1016/0003-2697(85)90097-1
52. Sinal CJ, Bend JR (1997) Aryl hydrocarbon receptor-dependent induction of cyp1a1 by bilirubin in mouse hepatoma hepa 1c1c7 cells. Mol Pharmacol 52:590-599
53. Tamási V, Fülöp AK, Hegyi K, Monostory K, Falus A (2003) Upregulation of cyp2e1 and cyp3a activities in histamine-deficient histidine decarboxylase gene targeted mice. Cell Biol Int 27:1011-1015. doi:10.1016/j.cellbi.2003.09.006
54. Tindberg N, Baldwin HA, Cross AJ, Ingelman-Sundberg M (1996) Induction of cytochrome P450 2E1 expression in rat and gerbil astrocytes by inflammatory factors and ischemic injury. Mol Pharmacol 50:1065-1072
55. Tsuchiya Y, Nakajima M, Yukoi T (2005) Cytochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Lett 227:115-124. doi:10.1016/j.canlet.2004.10.007
56. Yellin TO (1979) Histamine receptors. Medical and Scientific Books, New York
57. Wilkinson CF, Hetnarsky K, Yellin TO (1972) Imidazole derivates-a new class of microsomal enzyme inhibitors. Biochem Pharmacol 21:3187-3192. doi:10.1016/0006-2952(72)90147-5
58. Wilkinson CF, Hetnarsky K, Cantwell GP, Di Carlo FJ (1974) Structure-activity relationships in the effects of 1-alkylimidazoles on microsomal oxidation in vitro and in vivo. Biochem Pharmacol 23:2377-2386. doi:10.1016/0006-2952(74)90227-5